Therapeutic targeting of chromatin: status and opportunities.

Abstract excerpt

The molecular characterization of mechanisms underlying transcriptional control and epigenetic inheritance since the 1990s has paved the way for the development of targeted therapies that modulate these pathways. In the past two decades, cancer genome sequencing approaches have uncovered a plethora of mutations in chromatin modifying enzymes across tumor types, and systematic genetic screens have identified many...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Chromatin
• Share to Drugs, Investigational
• Share to Epigenesis, Genetic